Various prognostic markers have recently been evaluated, including the stem cell marker CD133 (Prominin-1), which was reported to be a cancer stem cell marker for cancers of the brain[2], colon[3,4], prostate[5], liver[6,7], lung[8], kidney[9], ovaries[10], and skin[11,12]. This evidence concerns the gene PROM1 and brain cancer.